COMPARATIVE ANALYSIS OF THE ACTION OF BUTYRYLPERAZINE AT MANHATTAN STATE HOSPITAL AND THE UNIVERSITY PSYCHIATRIC CLINIC AT ERLANGEN
Abstract
1. Butyrylperazine was administered to 20 patients at Manhattan State Hospital, New York City, and 26 patients at the University Psychiatric Clinic of Erlangen, West Germany.
2. There were significant differences between both groups in (a) dosage requirements, (b) side effects, and (c) clinical results.
3. It is suggested that genetic factors may play some role in explaining at least two of these findings (2a and b).
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
